Some questions deserve more than just answers — they deserve solutions. That's why when it comes to patient-centred outcomes research, the best pharma and biotechs ask Acaster Lloyd.
There is no disease specific measure, do I need to develop a new PRO/COA?
How can we demonstrate meaningful difference or meaningful change to support our label claim?
View services
Patient-reported
outcomes (PRO) /
clinical outcome
assessment (COA)
strategy and
instrument
development
I need a COA/PRO strategy that addresses the needs of multiple stakeholders.
I need help communicating our PRO/COA strategy with regulators.
